Results 111 to 120 of about 8,165 (189)

Febuxostat effectively reduces uric acid but has a limited renoprotective effect on renal transplant recipients with hyperuricemia: a meta-analysis. [PDF]

Front Pharmacol
Chao S, Zhu K, Jia L, Liu Y.
europepmc   +1 more source

Allopurinol and Febuxostat Hypersensitivity in a Patient with Young Onset Gout: A Case Report. [PDF]

Acta Med Philipp
Yano MAO, Magbitang-Santiago AT.
europepmc   +1 more source

Clinical Impact of Febuxostat in HFpEF Versus HFrEF: Insights from a Prospective Cohort. [PDF]

Balkan Med J
Ahsaan F, Latif B, Rehman Z.
europepmc   +1 more source

Response to Febuxostat in Elderly Gout Patients with Clinical Subtypes of Hyperuricemia: A Prospective Cohort Study. [PDF]

J Inflamm Res
Li J, Hu S, Ma L, Di S, Yan F, Gong Y, Li K, Huang X, Xu Y, Wang Y, Chen Y.   +10 more
europepmc   +1 more source

Febuxostat Improves MASLD in Male Rats: Roles of XOR Inhibition and Associated JNK/NRF2/HO-1 Pathway Changes. [PDF]

Int J Mol Sci
Pu Z, Cen Y, Yang B, Xing K, Lian L, Chi X, Yang J, Zhang Y.   +7 more
europepmc   +1 more source

Hepatic Safety of Febuxostat and Allopurinol in Gout Patients: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Ther Clin Risk Manag
Dewi C, Puspita F, Insani WN, Sinuraya RK, Puspitasari IM, Zakiyah N.   +5 more
europepmc   +1 more source

Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort study. [PDF]

Arthritis Res Ther
Guo K, Li C, Terkeltaub R, Dalbeth N, Wang X, Ji X, Chen Y, Cui L, Liu Z, Li X, He Y, Lu J, Sun W, Han L, Zhang H, Ji A, Sun M, Wang C.   +17 more
europepmc   +1 more source

Efficacy and safety of urate-lowering therapies in asymptomatic hyperuricaemia: a systematic review and network meta-analysis of key clinical outcomes. [PDF]

Ann Med
Yi Y, Yang J, Chen Y, Liu H, Deng Y.
europepmc   +1 more source

A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri). [PDF]

Sci Prog
Tsai SF, Wu MJ, Chen CH.
europepmc   +1 more source

Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study. [PDF]

Nephrology (Carlton)
Inoue R, Yamaguchi S, Okada A, Yamauchi T, Kadowaki T, Nangaku M.   +5 more
europepmc   +1 more source